Robin Deterding
Concepts (461)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 33 | 2024 | 507 | 8.110 |
Why?
| Pulmonary Surfactant-Associated Protein C | 9 | 2023 | 42 | 2.390 |
Why?
| Neuroendocrine Cells | 9 | 2020 | 30 | 2.250 |
Why?
| Respiration Disorders | 5 | 2019 | 69 | 1.740 |
Why?
| Bronchoalveolar Lavage Fluid | 7 | 2019 | 589 | 1.680 |
Why?
| Hyperplasia | 12 | 2022 | 163 | 1.640 |
Why?
| Glycogen Storage Disease | 3 | 2021 | 20 | 1.510 |
Why?
| Lung | 29 | 2024 | 3546 | 1.340 |
Why?
| Idiopathic Pulmonary Fibrosis | 5 | 2024 | 505 | 1.230 |
Why?
| Infant | 41 | 2024 | 7935 | 1.160 |
Why?
| Child | 67 | 2024 | 18352 | 1.130 |
Why?
| Machine Learning | 2 | 2019 | 318 | 1.050 |
Why?
| Cystic Fibrosis | 7 | 2019 | 955 | 1.050 |
Why?
| Proteomics | 6 | 2023 | 843 | 1.000 |
Why?
| Child, Preschool | 37 | 2024 | 9079 | 1.000 |
Why?
| Pediatrics | 8 | 2015 | 983 | 0.940 |
Why?
| Tomography, X-Ray Computed | 16 | 2024 | 2269 | 0.900 |
Why?
| Oxygen Inhalation Therapy | 5 | 2019 | 129 | 0.840 |
Why?
| Mutation | 14 | 2024 | 3350 | 0.790 |
Why?
| Bronchiectasis | 3 | 2024 | 106 | 0.760 |
Why?
| Humans | 101 | 2024 | 114756 | 0.720 |
Why?
| Immunologic Techniques | 1 | 2019 | 39 | 0.690 |
Why?
| Home Care Services | 2 | 2019 | 222 | 0.650 |
Why?
| Biopsy | 14 | 2019 | 1040 | 0.640 |
Why?
| Allergy and Immunology | 1 | 2019 | 51 | 0.640 |
Why?
| Sleep Wake Disorders | 2 | 2020 | 233 | 0.630 |
Why?
| Nocturnal Myoclonus Syndrome | 1 | 2018 | 5 | 0.620 |
Why?
| Hypoxia | 4 | 2018 | 957 | 0.610 |
Why?
| Asthma | 3 | 2019 | 2032 | 0.610 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2019 | 102 | 0.610 |
Why?
| Aptamers, Nucleotide | 1 | 2019 | 73 | 0.600 |
Why?
| Lung Diseases | 8 | 2020 | 696 | 0.580 |
Why?
| Male | 51 | 2023 | 55579 | 0.550 |
Why?
| Deoxycytosine Nucleotides | 2 | 2007 | 11 | 0.530 |
Why?
| Uridine | 2 | 2007 | 29 | 0.530 |
Why?
| Female | 50 | 2024 | 59507 | 0.530 |
Why?
| Hypertension, Pulmonary | 7 | 2024 | 1728 | 0.500 |
Why?
| Pulmonary Alveoli | 7 | 2021 | 372 | 0.500 |
Why?
| Pulmonary Surfactants | 8 | 2013 | 100 | 0.490 |
Why?
| Respiratory Function Tests | 9 | 2018 | 524 | 0.470 |
Why?
| Clinical Clerkship | 6 | 2007 | 72 | 0.470 |
Why?
| Respiration, Artificial | 4 | 2021 | 526 | 0.460 |
Why?
| Retrospective Studies | 24 | 2024 | 12515 | 0.460 |
Why?
| Adolescent | 31 | 2024 | 17808 | 0.450 |
Why?
| Household Articles | 1 | 2014 | 23 | 0.450 |
Why?
| Disinfectants | 1 | 2014 | 34 | 0.440 |
Why?
| Research | 2 | 2020 | 394 | 0.440 |
Why?
| Pulmonary Surfactant-Associated Protein B | 3 | 2010 | 5 | 0.440 |
Why?
| Growth Substances | 6 | 2000 | 136 | 0.420 |
Why?
| Bronchiolitis | 1 | 2013 | 81 | 0.410 |
Why?
| Esophagoscopy | 3 | 2019 | 184 | 0.390 |
Why?
| International Classification of Diseases | 1 | 2012 | 117 | 0.390 |
Why?
| Infant, Newborn | 17 | 2019 | 5035 | 0.390 |
Why?
| Polyendocrinopathies, Autoimmune | 1 | 2011 | 18 | 0.390 |
Why?
| ATP-Binding Cassette Transporters | 5 | 2014 | 123 | 0.380 |
Why?
| Neurosecretory Systems | 3 | 2010 | 32 | 0.380 |
Why?
| Program Development | 2 | 2018 | 342 | 0.380 |
Why?
| Humidity | 1 | 2011 | 37 | 0.370 |
Why?
| Potassium Channels | 1 | 2011 | 121 | 0.370 |
Why?
| Fibroblast Growth Factors | 5 | 2000 | 162 | 0.360 |
Why?
| Computer Simulation | 4 | 2018 | 878 | 0.360 |
Why?
| Dust | 1 | 2011 | 84 | 0.350 |
Why?
| Inhalation Exposure | 1 | 2011 | 97 | 0.350 |
Why?
| Rare Diseases | 3 | 2020 | 89 | 0.340 |
Why?
| Diagnosis, Differential | 6 | 2019 | 1340 | 0.340 |
Why?
| Pulmonary Alveolar Proteinosis | 2 | 2023 | 16 | 0.340 |
Why?
| Eosinophilic Esophagitis | 3 | 2019 | 296 | 0.320 |
Why?
| Purinergic P2 Receptor Agonists | 2 | 2007 | 4 | 0.320 |
Why?
| Autoimmune Diseases | 3 | 2024 | 391 | 0.320 |
Why?
| Immunologic Factors | 2 | 2011 | 220 | 0.310 |
Why?
| Lung Injury | 1 | 2011 | 197 | 0.310 |
Why?
| Education, Medical, Undergraduate | 2 | 2007 | 159 | 0.310 |
Why?
| Tomography | 2 | 2018 | 21 | 0.310 |
Why?
| Curriculum | 2 | 2007 | 825 | 0.300 |
Why?
| Case-Control Studies | 6 | 2019 | 3005 | 0.300 |
Why?
| Problem-Based Learning | 3 | 2006 | 78 | 0.290 |
Why?
| Cytokines | 2 | 2019 | 1843 | 0.280 |
Why?
| Respiratory Tract Diseases | 2 | 2019 | 139 | 0.280 |
Why?
| Gastrointestinal Diseases | 2 | 2018 | 183 | 0.270 |
Why?
| Pneumonia | 2 | 2019 | 566 | 0.270 |
Why?
| Double-Blind Method | 3 | 2023 | 1662 | 0.250 |
Why?
| Practice Guidelines as Topic | 3 | 2019 | 1393 | 0.250 |
Why?
| Bronchodilator Agents | 1 | 2006 | 240 | 0.230 |
Why?
| United States | 9 | 2023 | 12176 | 0.230 |
Why?
| Biomarkers | 5 | 2019 | 3416 | 0.230 |
Why?
| Receptors, CCR2 | 1 | 2023 | 28 | 0.230 |
Why?
| Hernia, Diaphragmatic | 1 | 2003 | 66 | 0.220 |
Why?
| Pleural Effusion | 1 | 2003 | 47 | 0.220 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 299 | 0.220 |
Why?
| Disease Progression | 2 | 2023 | 2387 | 0.220 |
Why?
| Severity of Illness Index | 3 | 2020 | 2539 | 0.210 |
Why?
| Thyroid Nuclear Factor 1 | 3 | 2019 | 14 | 0.200 |
Why?
| Vital Capacity | 1 | 2023 | 256 | 0.200 |
Why?
| Arthritis, Juvenile | 2 | 2019 | 42 | 0.200 |
Why?
| Heart Defects, Congenital | 3 | 2018 | 665 | 0.200 |
Why?
| Education, Medical | 1 | 2005 | 216 | 0.200 |
Why?
| Self-Evaluation Programs | 2 | 1999 | 6 | 0.200 |
Why?
| Bronchiolitis Obliterans | 2 | 2021 | 66 | 0.190 |
Why?
| Bronchoscopy | 3 | 2018 | 246 | 0.190 |
Why?
| Epstein-Barr Virus Infections | 1 | 2022 | 72 | 0.190 |
Why?
| Immunocompromised Host | 2 | 2015 | 195 | 0.190 |
Why?
| Protein C | 1 | 2021 | 45 | 0.180 |
Why?
| Stevens-Johnson Syndrome | 1 | 2021 | 34 | 0.180 |
Why?
| Fibrosis | 1 | 2023 | 453 | 0.180 |
Why?
| Thinking | 1 | 2001 | 53 | 0.180 |
Why?
| Immunologic Deficiency Syndromes | 1 | 2000 | 61 | 0.170 |
Why?
| Pulmonary Medicine | 2 | 2019 | 87 | 0.170 |
Why?
| Proteolipids | 2 | 2000 | 28 | 0.170 |
Why?
| Foundations | 2 | 2020 | 22 | 0.170 |
Why?
| Heart Diseases | 1 | 2023 | 330 | 0.170 |
Why?
| Genetic Predisposition to Disease | 3 | 2019 | 2099 | 0.170 |
Why?
| Respiratory Rate | 1 | 2019 | 18 | 0.160 |
Why?
| Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| Chorea | 1 | 2019 | 11 | 0.160 |
Why?
| Congenital Hypothyroidism | 1 | 2019 | 11 | 0.160 |
Why?
| Infant, Newborn, Diseases | 1 | 2001 | 104 | 0.160 |
Why?
| Otorhinolaryngologic Diseases | 1 | 2019 | 13 | 0.160 |
Why?
| Digestive System Diseases | 1 | 2019 | 23 | 0.160 |
Why?
| User-Computer Interface | 3 | 2006 | 141 | 0.160 |
Why?
| Societies | 1 | 2019 | 38 | 0.160 |
Why?
| Preceptorship | 1 | 1999 | 62 | 0.160 |
Why?
| Colorado | 6 | 2019 | 4086 | 0.160 |
Why?
| Educational Measurement | 1 | 2001 | 244 | 0.160 |
Why?
| Oximetry | 1 | 2019 | 81 | 0.160 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2019 | 91 | 0.160 |
Why?
| Down Syndrome | 1 | 2023 | 338 | 0.150 |
Why?
| Virtual Reality | 1 | 2019 | 38 | 0.150 |
Why?
| Air | 1 | 2018 | 33 | 0.150 |
Why?
| Bronchi | 2 | 2015 | 232 | 0.150 |
Why?
| Esophageal Mucosa | 1 | 2018 | 17 | 0.150 |
Why?
| Models, Anatomic | 1 | 2018 | 87 | 0.150 |
Why?
| Research Design | 2 | 2023 | 931 | 0.150 |
Why?
| Fibroblast Growth Factor 1 | 2 | 1996 | 11 | 0.150 |
Why?
| Polysomnography | 1 | 2018 | 139 | 0.150 |
Why?
| Radiography | 3 | 2013 | 811 | 0.150 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 98 | 0.150 |
Why?
| Pneumonia, Lipid | 1 | 2017 | 3 | 0.150 |
Why?
| Autophagy | 2 | 2022 | 233 | 0.140 |
Why?
| Lymphocytes | 1 | 2019 | 332 | 0.140 |
Why?
| Respiration | 1 | 2018 | 179 | 0.140 |
Why?
| Respiratory Sounds | 2 | 2010 | 111 | 0.140 |
Why?
| Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.140 |
Why?
| Bronchial Arteries | 1 | 2017 | 11 | 0.140 |
Why?
| Internal Medicine | 1 | 1999 | 211 | 0.140 |
Why?
| Prognosis | 5 | 2024 | 3334 | 0.140 |
Why?
| Gastrostomy | 1 | 2018 | 89 | 0.140 |
Why?
| Membrane Proteins | 2 | 2022 | 1022 | 0.140 |
Why?
| Young Adult | 8 | 2019 | 10463 | 0.140 |
Why?
| Disease Management | 3 | 2019 | 560 | 0.140 |
Why?
| Adult | 12 | 2024 | 30548 | 0.140 |
Why?
| Clinical Competence | 3 | 2018 | 896 | 0.140 |
Why?
| Gastroesophageal Reflux | 2 | 2015 | 234 | 0.140 |
Why?
| Delivery of Health Care, Integrated | 1 | 2019 | 228 | 0.130 |
Why?
| Lung Transplantation | 2 | 2015 | 246 | 0.130 |
Why?
| Pulmonary Artery | 2 | 2024 | 1012 | 0.130 |
Why?
| Pulmonary Fibrosis | 1 | 2019 | 322 | 0.130 |
Why?
| Mutation, Missense | 2 | 2014 | 295 | 0.130 |
Why?
| Registries | 1 | 2023 | 1759 | 0.130 |
Why?
| Bleomycin | 1 | 1997 | 228 | 0.130 |
Why?
| Comorbidity | 1 | 2020 | 1449 | 0.130 |
Why?
| Heart Rate | 1 | 2019 | 704 | 0.130 |
Why?
| Gestational Age | 1 | 2018 | 759 | 0.130 |
Why?
| Imaging, Three-Dimensional | 2 | 2017 | 513 | 0.130 |
Why?
| Patient Care Team | 2 | 2018 | 517 | 0.130 |
Why?
| Patient Satisfaction | 2 | 2019 | 583 | 0.130 |
Why?
| Esophageal Atresia | 1 | 2015 | 26 | 0.130 |
Why?
| Pulmonary Surgical Procedures | 1 | 2015 | 8 | 0.130 |
Why?
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 26 | 0.120 |
Why?
| Tracheoesophageal Fistula | 1 | 2015 | 32 | 0.120 |
Why?
| Family Practice | 1 | 1999 | 427 | 0.120 |
Why?
| Thyroid Gland | 1 | 2015 | 84 | 0.120 |
Why?
| Clinical Trials as Topic | 1 | 2019 | 935 | 0.120 |
Why?
| Pregnancy Trimester, First | 1 | 2015 | 125 | 0.120 |
Why?
| Pluripotent Stem Cells | 1 | 2015 | 63 | 0.120 |
Why?
| Phenotype | 3 | 2018 | 2812 | 0.120 |
Why?
| Adrenal Cortex Hormones | 1 | 2018 | 498 | 0.120 |
Why?
| Delayed Diagnosis | 1 | 2015 | 70 | 0.120 |
Why?
| Angiography | 1 | 2015 | 174 | 0.120 |
Why?
| Genetic Diseases, Inborn | 1 | 2014 | 36 | 0.120 |
Why?
| Cell Differentiation | 3 | 2015 | 1699 | 0.120 |
Why?
| Treatment Outcome | 6 | 2015 | 9089 | 0.120 |
Why?
| Chest Tubes | 1 | 2014 | 30 | 0.120 |
Why?
| Societies, Medical | 2 | 2019 | 663 | 0.120 |
Why?
| Ambulatory Care | 1 | 2018 | 479 | 0.110 |
Why?
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 40 | 0.110 |
Why?
| Software | 1 | 1998 | 536 | 0.110 |
Why?
| Regeneration | 1 | 2015 | 160 | 0.110 |
Why?
| Image Processing, Computer-Assisted | 1 | 2018 | 684 | 0.110 |
Why?
| Deglutition Disorders | 1 | 2015 | 119 | 0.110 |
Why?
| Electric Impedance | 3 | 2018 | 100 | 0.110 |
Why?
| Abnormalities, Multiple | 1 | 2015 | 177 | 0.110 |
Why?
| Follow-Up Studies | 4 | 2019 | 4420 | 0.110 |
Why?
| Diagnostic Techniques, Respiratory System | 1 | 2013 | 5 | 0.110 |
Why?
| Blood Proteins | 1 | 2015 | 232 | 0.110 |
Why?
| Autoimmunity | 1 | 2019 | 814 | 0.110 |
Why?
| DNA Mutational Analysis | 2 | 2013 | 372 | 0.110 |
Why?
| Glycoproteins | 2 | 2000 | 304 | 0.110 |
Why?
| Critical Care | 1 | 2017 | 473 | 0.110 |
Why?
| Evidence-Based Medicine | 1 | 2017 | 667 | 0.110 |
Why?
| Homozygote | 1 | 2013 | 187 | 0.110 |
Why?
| Airway Obstruction | 1 | 2015 | 168 | 0.110 |
Why?
| Pedigree | 2 | 2013 | 464 | 0.110 |
Why?
| Device Removal | 1 | 2014 | 126 | 0.110 |
Why?
| Mucin-5B | 1 | 2015 | 183 | 0.110 |
Why?
| Schools, Medical | 2 | 2007 | 120 | 0.110 |
Why?
| Autoantibodies | 3 | 2019 | 1350 | 0.100 |
Why?
| Plethysmography | 1 | 2012 | 104 | 0.100 |
Why?
| Familial Primary Pulmonary Hypertension | 2 | 2024 | 190 | 0.100 |
Why?
| Leukocytes | 1 | 2013 | 277 | 0.100 |
Why?
| Premature Birth | 1 | 2015 | 276 | 0.100 |
Why?
| Spirometry | 1 | 2012 | 225 | 0.100 |
Why?
| Internship and Residency | 2 | 2018 | 932 | 0.100 |
Why?
| Fibroblast Growth Factor 7 | 5 | 2000 | 16 | 0.100 |
Why?
| Fibroblast Growth Factor 10 | 5 | 2000 | 24 | 0.100 |
Why?
| World Health Organization | 1 | 2012 | 103 | 0.100 |
Why?
| Models, Statistical | 1 | 2015 | 604 | 0.100 |
Why?
| Hydrocortisone | 1 | 1994 | 269 | 0.100 |
Why?
| Cardiac Catheterization | 1 | 2015 | 534 | 0.100 |
Why?
| Physicians | 1 | 2019 | 772 | 0.100 |
Why?
| Genetic Counseling | 2 | 2015 | 65 | 0.100 |
Why?
| Rats, Sprague-Dawley | 5 | 1997 | 2209 | 0.100 |
Why?
| Epithelial Cells | 4 | 2015 | 955 | 0.090 |
Why?
| Bronchoalveolar Lavage | 3 | 2007 | 84 | 0.090 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 82 | 0.090 |
Why?
| Laryngeal Diseases | 1 | 2011 | 21 | 0.090 |
Why?
| Rats | 8 | 2000 | 4943 | 0.090 |
Why?
| Bromhexine | 1 | 2010 | 1 | 0.090 |
Why?
| Referral and Consultation | 1 | 2015 | 632 | 0.090 |
Why?
| Granulomatosis with Polyangiitis | 1 | 2011 | 41 | 0.090 |
Why?
| Rituximab | 1 | 2011 | 150 | 0.090 |
Why?
| Syndrome | 1 | 2011 | 334 | 0.090 |
Why?
| Anti-Bacterial Agents | 2 | 2013 | 1477 | 0.090 |
Why?
| Intestinal Mucosa | 1 | 2015 | 530 | 0.090 |
Why?
| Nuclear Proteins | 2 | 2013 | 592 | 0.090 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2011 | 86 | 0.090 |
Why?
| Diagnostic Imaging | 2 | 2015 | 275 | 0.090 |
Why?
| Body Mass Index | 1 | 2017 | 1958 | 0.090 |
Why?
| Uniparental Disomy | 1 | 2009 | 7 | 0.080 |
Why?
| Microscopy, Electron | 3 | 2013 | 410 | 0.080 |
Why?
| Uteroglobin | 2 | 2000 | 16 | 0.080 |
Why?
| Mucin-1 | 1 | 2009 | 18 | 0.080 |
Why?
| Lipid Metabolism, Inborn Errors | 1 | 2009 | 16 | 0.080 |
Why?
| Neutrophils | 1 | 2013 | 1163 | 0.080 |
Why?
| Cell Division | 4 | 2000 | 759 | 0.070 |
Why?
| DNA | 2 | 2013 | 1351 | 0.070 |
Why?
| Cytogenetic Analysis | 1 | 2007 | 29 | 0.070 |
Why?
| Lung Volume Measurements | 1 | 2007 | 45 | 0.070 |
Why?
| Medical History Taking | 2 | 2005 | 114 | 0.070 |
Why?
| Delphi Technique | 2 | 2018 | 160 | 0.070 |
Why?
| Transcription Factors | 2 | 2013 | 1528 | 0.070 |
Why?
| Respiratory Tract Infections | 1 | 2011 | 319 | 0.070 |
Why?
| Consensus | 2 | 2020 | 535 | 0.070 |
Why?
| Nebulizers and Vaporizers | 1 | 2007 | 78 | 0.070 |
Why?
| Logistic Models | 3 | 2015 | 1843 | 0.070 |
Why?
| DNA, Bacterial | 1 | 2007 | 310 | 0.070 |
Why?
| Cough | 1 | 2007 | 107 | 0.070 |
Why?
| Animals | 12 | 2019 | 31761 | 0.070 |
Why?
| Cross-Sectional Studies | 2 | 2015 | 4409 | 0.070 |
Why?
| Prospective Studies | 4 | 2023 | 6217 | 0.070 |
Why?
| Computer-Assisted Instruction | 1 | 2006 | 62 | 0.060 |
Why?
| Forced Expiratory Volume | 2 | 2005 | 476 | 0.060 |
Why?
| Respiratory Mucosa | 2 | 2014 | 251 | 0.060 |
Why?
| Receptors, Purinergic P2Y2 | 1 | 2005 | 5 | 0.060 |
Why?
| Administration, Inhalation | 2 | 2005 | 642 | 0.060 |
Why?
| Faculty, Medical | 1 | 2007 | 228 | 0.060 |
Why?
| Intraoperative Period | 2 | 2015 | 50 | 0.060 |
Why?
| Age Distribution | 1 | 2005 | 339 | 0.060 |
Why?
| Teaching | 1 | 2006 | 214 | 0.060 |
Why?
| Program Evaluation | 2 | 2019 | 822 | 0.060 |
Why?
| Age of Onset | 1 | 2005 | 448 | 0.060 |
Why?
| T-Box Domain Proteins | 1 | 2024 | 92 | 0.050 |
Why?
| Pulmonary Veno-Occlusive Disease | 1 | 2003 | 11 | 0.050 |
Why?
| Genetic Testing | 1 | 2005 | 379 | 0.050 |
Why?
| Cohort Studies | 3 | 2023 | 4901 | 0.050 |
Why?
| Patient Simulation | 1 | 2003 | 29 | 0.050 |
Why?
| Macrophages, Alveolar | 2 | 2023 | 347 | 0.050 |
Why?
| Terminology as Topic | 2 | 2018 | 187 | 0.050 |
Why?
| Autophagy-Related Proteins | 1 | 2022 | 39 | 0.050 |
Why?
| Methylprednisolone | 2 | 2013 | 82 | 0.050 |
Why?
| Neuroblastoma | 1 | 2003 | 132 | 0.050 |
Why?
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 48 | 0.050 |
Why?
| Disease Models, Animal | 3 | 2019 | 3542 | 0.050 |
Why?
| Bone Marrow Transplantation | 1 | 2003 | 241 | 0.050 |
Why?
| Data Collection | 1 | 2005 | 622 | 0.050 |
Why?
| Herpesvirus 4, Human | 1 | 2022 | 125 | 0.050 |
Why?
| Genotype | 2 | 2018 | 1774 | 0.050 |
Why?
| Bacteria | 1 | 2007 | 726 | 0.050 |
Why?
| Vesicular Transport Proteins | 1 | 2022 | 83 | 0.050 |
Why?
| Neoplasms | 1 | 2015 | 2105 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 213 | 0.050 |
Why?
| RNA, Messenger | 4 | 2000 | 2557 | 0.050 |
Why?
| Surface-Active Agents | 1 | 2021 | 79 | 0.050 |
Why?
| Combined Modality Therapy | 2 | 2015 | 1122 | 0.040 |
Why?
| Group Processes | 1 | 2001 | 53 | 0.040 |
Why?
| Models, Educational | 1 | 2001 | 84 | 0.040 |
Why?
| Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 10 | 0.040 |
Why?
| Immunohistochemistry | 2 | 2015 | 1635 | 0.040 |
Why?
| Incidence | 2 | 2019 | 2312 | 0.040 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 493 | 0.040 |
Why?
| Pemphigus | 1 | 1999 | 8 | 0.040 |
Why?
| Heart | 1 | 2023 | 609 | 0.040 |
Why?
| Paraneoplastic Syndromes | 1 | 1999 | 12 | 0.040 |
Why?
| Speech-Language Pathology | 1 | 2019 | 16 | 0.040 |
Why?
| Anti-Inflammatory Agents | 2 | 2013 | 450 | 0.040 |
Why?
| Pulmonary Surfactant-Associated Protein D | 2 | 2000 | 29 | 0.040 |
Why?
| Esophageal pH Monitoring | 1 | 2018 | 23 | 0.040 |
Why?
| NF-kappa B | 1 | 2022 | 636 | 0.040 |
Why?
| Hospital Information Systems | 1 | 1998 | 13 | 0.040 |
Why?
| Formative Feedback | 1 | 2018 | 22 | 0.040 |
Why?
| Alveolar Epithelial Cells | 1 | 2019 | 93 | 0.040 |
Why?
| Computer Communication Networks | 1 | 1998 | 32 | 0.040 |
Why?
| Efficiency, Organizational | 1 | 2019 | 126 | 0.040 |
Why?
| Interdisciplinary Research | 1 | 2018 | 25 | 0.040 |
Why?
| Otolaryngology | 1 | 2019 | 70 | 0.040 |
Why?
| Endoscopy, Digestive System | 1 | 2019 | 110 | 0.040 |
Why?
| Macrophage Activation Syndrome | 1 | 2017 | 12 | 0.040 |
Why?
| Drug Antagonism | 1 | 1997 | 8 | 0.040 |
Why?
| Fundoplication | 1 | 1997 | 51 | 0.040 |
Why?
| Hydroxyproline | 1 | 1997 | 22 | 0.040 |
Why?
| Receptor Protein-Tyrosine Kinases | 2 | 1996 | 227 | 0.040 |
Why?
| Gene Expression | 3 | 2000 | 1420 | 0.040 |
Why?
| Information Storage and Retrieval | 1 | 1998 | 107 | 0.040 |
Why?
| Early Diagnosis | 1 | 2018 | 216 | 0.040 |
Why?
| Review Literature as Topic | 1 | 2017 | 61 | 0.040 |
Why?
| Endoplasmic Reticulum | 1 | 2019 | 234 | 0.030 |
Why?
| Hydrochloric Acid | 1 | 1996 | 8 | 0.030 |
Why?
| Esophagus | 1 | 2019 | 226 | 0.030 |
Why?
| Gastroenterology | 1 | 2019 | 159 | 0.030 |
Why?
| Cholera Toxin | 1 | 1996 | 27 | 0.030 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1996 | 21 | 0.030 |
Why?
| Trachea | 1 | 2018 | 223 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2023 | 2386 | 0.030 |
Why?
| Ambulatory Care Facilities | 1 | 2018 | 212 | 0.030 |
Why?
| Receptors, Fibroblast Growth Factor | 1 | 1996 | 63 | 0.030 |
Why?
| Culture Media | 1 | 1996 | 155 | 0.030 |
Why?
| Monitoring, Physiologic | 1 | 2018 | 248 | 0.030 |
Why?
| Analysis of Variance | 1 | 1999 | 1226 | 0.030 |
Why?
| Organ Size | 1 | 1997 | 435 | 0.030 |
Why?
| Mice | 3 | 2019 | 14916 | 0.030 |
Why?
| Cyclic AMP | 1 | 1996 | 225 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2019 | 479 | 0.030 |
Why?
| Respiratory Insufficiency | 1 | 1999 | 291 | 0.030 |
Why?
| Survival Rate | 1 | 2019 | 1642 | 0.030 |
Why?
| Sampling Studies | 1 | 2015 | 93 | 0.030 |
Why?
| Xenopus | 1 | 2015 | 98 | 0.030 |
Why?
| Embryonic Induction | 1 | 1995 | 30 | 0.030 |
Why?
| Principal Component Analysis | 1 | 2015 | 176 | 0.030 |
Why?
| Mouth | 1 | 2015 | 69 | 0.030 |
Why?
| Laminin | 1 | 1995 | 69 | 0.030 |
Why?
| Vimentin | 1 | 1995 | 58 | 0.030 |
Why?
| Gene Expression Regulation | 2 | 2014 | 2321 | 0.030 |
Why?
| Health Services Research | 1 | 2018 | 371 | 0.030 |
Why?
| Long-Term Care | 1 | 2015 | 77 | 0.030 |
Why?
| Ventilator-Induced Lung Injury | 1 | 2015 | 49 | 0.030 |
Why?
| Prevalence | 2 | 2011 | 2249 | 0.030 |
Why?
| Demography | 1 | 2015 | 262 | 0.030 |
Why?
| Autophagy-Related Protein 8 Family | 1 | 2014 | 2 | 0.030 |
Why?
| Proteostasis Deficiencies | 1 | 2014 | 6 | 0.030 |
Why?
| Sequestosome-1 Protein | 1 | 2014 | 13 | 0.030 |
Why?
| Vacuoles | 1 | 2014 | 33 | 0.030 |
Why?
| Hepatocyte Growth Factor | 1 | 1994 | 32 | 0.030 |
Why?
| North America | 1 | 2015 | 257 | 0.030 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2014 | 55 | 0.030 |
Why?
| Proteoglycans | 1 | 1995 | 107 | 0.030 |
Why?
| Persistent Fetal Circulation Syndrome | 1 | 2015 | 132 | 0.030 |
Why?
| Cardiovascular Agents | 1 | 2015 | 125 | 0.030 |
Why?
| Fatal Outcome | 2 | 2009 | 284 | 0.030 |
Why?
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 172 | 0.030 |
Why?
| ROC Curve | 1 | 2015 | 445 | 0.030 |
Why?
| Quality of Health Care | 1 | 2019 | 573 | 0.030 |
Why?
| Drug Combinations | 1 | 1995 | 286 | 0.030 |
Why?
| Mesoderm | 1 | 1995 | 138 | 0.030 |
Why?
| B-Lymphocytes | 1 | 2019 | 769 | 0.030 |
Why?
| rab GTP-Binding Proteins | 1 | 2014 | 63 | 0.030 |
Why?
| Lysosomes | 1 | 2014 | 123 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 78 | 0.030 |
Why?
| Consanguinity | 1 | 2013 | 47 | 0.030 |
Why?
| Embryonic and Fetal Development | 1 | 1994 | 94 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2014 | 262 | 0.030 |
Why?
| Microfilament Proteins | 1 | 2014 | 127 | 0.030 |
Why?
| Rats, Inbred F344 | 3 | 2000 | 241 | 0.030 |
Why?
| Middle Aged | 2 | 2019 | 26757 | 0.030 |
Why?
| Genes, Recessive | 1 | 2013 | 73 | 0.030 |
Why?
| Transcriptome | 1 | 2019 | 727 | 0.030 |
Why?
| Drainage | 1 | 2014 | 151 | 0.030 |
Why?
| Laparoscopy | 1 | 1997 | 388 | 0.030 |
Why?
| Hydroxychloroquine | 1 | 2013 | 55 | 0.030 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2014 | 139 | 0.030 |
Why?
| Microtubule-Associated Proteins | 1 | 2014 | 174 | 0.030 |
Why?
| Radiography, Thoracic | 1 | 2014 | 148 | 0.030 |
Why?
| In Vitro Techniques | 1 | 1995 | 1013 | 0.030 |
Why?
| Azithromycin | 1 | 2013 | 80 | 0.030 |
Why?
| Pregnancy | 2 | 2015 | 5525 | 0.030 |
Why?
| Hernias, Diaphragmatic, Congenital | 1 | 2015 | 186 | 0.030 |
Why?
| Collagen | 1 | 1995 | 415 | 0.030 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 240 | 0.030 |
Why?
| Maternal-Fetal Exchange | 1 | 1994 | 151 | 0.030 |
Why?
| Mice, Knockout | 1 | 2019 | 2582 | 0.030 |
Why?
| Siblings | 1 | 2013 | 222 | 0.030 |
Why?
| Pain, Postoperative | 1 | 2014 | 191 | 0.030 |
Why?
| Pandemics | 1 | 2020 | 1319 | 0.030 |
Why?
| HEK293 Cells | 1 | 2014 | 593 | 0.030 |
Why?
| Algorithms | 2 | 2015 | 1468 | 0.030 |
Why?
| Stem Cell Transplantation | 1 | 2013 | 149 | 0.030 |
Why?
| Risk Factors | 2 | 2015 | 8627 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 368 | 0.020 |
Why?
| Congresses as Topic | 1 | 2013 | 196 | 0.020 |
Why?
| Dexamethasone | 1 | 1994 | 317 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2019 | 1745 | 0.020 |
Why?
| Denmark | 1 | 2011 | 39 | 0.020 |
Why?
| Laryngostenosis | 1 | 2011 | 20 | 0.020 |
Why?
| Granuloma | 1 | 2011 | 83 | 0.020 |
Why?
| Cells, Cultured | 2 | 1995 | 3890 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2015 | 1133 | 0.020 |
Why?
| Nitric Oxide | 1 | 2015 | 824 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2015 | 1951 | 0.020 |
Why?
| Pilot Projects | 1 | 2015 | 1370 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2014 | 435 | 0.020 |
Why?
| Cell Line | 1 | 2015 | 2639 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 4710 | 0.020 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2009 | 27 | 0.020 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2009 | 30 | 0.020 |
Why?
| Mitochondria | 1 | 2014 | 751 | 0.020 |
Why?
| DNA Methylation | 1 | 2013 | 496 | 0.020 |
Why?
| Time Factors | 1 | 2019 | 6124 | 0.020 |
Why?
| Specific Pathogen-Free Organisms | 2 | 2000 | 59 | 0.020 |
Why?
| Biomedical Research | 1 | 2014 | 585 | 0.020 |
Why?
| Genes, rRNA | 1 | 2007 | 39 | 0.020 |
Why?
| Endocrine System Diseases | 1 | 2007 | 30 | 0.020 |
Why?
| Genes, Bacterial | 1 | 2007 | 157 | 0.020 |
Why?
| Growth Disorders | 1 | 2007 | 77 | 0.020 |
Why?
| Risk Assessment | 1 | 2015 | 2973 | 0.020 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 916 | 0.020 |
Why?
| Chronic Disease | 1 | 2011 | 1590 | 0.020 |
Why?
| Postoperative Complications | 1 | 2015 | 2127 | 0.020 |
Why?
| Nervous System Diseases | 1 | 2007 | 252 | 0.010 |
Why?
| Signal Transduction | 1 | 1996 | 4521 | 0.010 |
Why?
| Inflammation | 1 | 2014 | 2481 | 0.010 |
Why?
| CD-ROM | 1 | 2003 | 6 | 0.010 |
Why?
| Proteins | 2 | 2000 | 912 | 0.010 |
Why?
| Teaching Materials | 1 | 2003 | 25 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2007 | 2791 | 0.010 |
Why?
| Transplantation, Autologous | 1 | 2003 | 176 | 0.010 |
Why?
| Statistics, Nonparametric | 1 | 2003 | 386 | 0.010 |
Why?
| Pulmonary Surfactant-Associated Protein A | 1 | 2000 | 24 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 2000 | 72 | 0.010 |
Why?
| In Situ Hybridization | 1 | 2000 | 293 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2003 | 1176 | 0.010 |
Why?
| Acantholysis | 1 | 1999 | 2 | 0.010 |
Why?
| Castleman Disease | 1 | 1999 | 12 | 0.010 |
Why?
| Internet | 1 | 2003 | 596 | 0.010 |
Why?
| Lymphoma, B-Cell | 1 | 1999 | 86 | 0.010 |
Why?
| Epithelium | 1 | 1999 | 297 | 0.010 |
Why?
| Adolescent Behavior | 1 | 2003 | 489 | 0.010 |
Why?
| Phospholipases A | 1 | 1997 | 101 | 0.010 |
Why?
| Clinical Protocols | 1 | 1998 | 232 | 0.010 |
Why?
| Physical Examination | 1 | 1998 | 220 | 0.010 |
Why?
| Cell Count | 1 | 1996 | 305 | 0.010 |
Why?
| Immunoglobulin G | 1 | 1999 | 774 | 0.010 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 1994 | 69 | 0.010 |
Why?
| Age Factors | 1 | 2000 | 2890 | 0.010 |
Why?
|
|
Deterding's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|